Vaxican is a small enterprise with high ambitions, that was born as a result of work on research projects carried out at the Department of Recombinant Vaccines at the Intercollegiate Faculty of Biotechnology of the University of Gdansk and the Medical University of Gdansk. Our Strat-up is working on innovative vaccine development platform based on virus-like particles, suitable for the production of prophylactic vaccines against infectious diseases in humans and animals and which can be used to produce therapeutic vaccines in cancer We’ve got a wonderful team of people, all of us are really passionate about using this approach to transform medicine, starting with cancer, but really there is a huge spectrum of diseases that we can approach. In addition, we’re fortunate to have the amazing advice from unique cluster of thought leaders in oncology, and related sciences, working in renowned European institutions. We also conduct research and provide services in the field of Next Generation Sequencing. In the last year our company had secured a 1.5 mln Euro government contract for sequencing SARS Cov-2 till the end of 2022.